Staging and natural history of cerebrovascular pathology in dementia
- PMID: 22377814
- PMCID: PMC3317531
- DOI: 10.1212/WNL.0b013e31824e8e7f
Staging and natural history of cerebrovascular pathology in dementia
Abstract
Objective: Most pathologic studies indicate that significant vascular changes are found in the majority of elderly persons, either alone or in association with neurodegenerative processes such as Alzheimer disease (AD) or dementia with Lewy bodies (DLB). Cumulative burden of cerebrovascular lesions can explain cognitive decline described as vascular cognitive impairment, but because there is a lack of consensus in the best way to quantify vascular pathology, the relationship between cognitive decline and cerebrovascular disease remains uncertain. We developed a rating scheme for cerebrovascular lesions using postmortem brains from patients with dementia from 2 European tertiary care memory clinics.
Methods: A total of 135 brains with a neuropathologic diagnosis of vascular dementia (VaD) (n = 26), AD + VaD (n = 39), DLB + VaD (n = 21), AD + DLB + VaD (n = 9), AD (n = 19), and DLB (n = 21) were investigated in this study. Cerebrovascular lesions were rated on large sections from the hippocampus, the temporal lobe, the frontal lobe, and basal ganglia.
Results: In patients with dementia, vessel wall modifications such as arteriolosclerosis or amyloid angiopathy are the most common and presumably the earliest changes. Modifications in perivascular spaces and myelin loss are the next most common. Lacunar or regional infarcts may occur as a consequence of an independent process or in the final phase of small vessel diseases.
Conclusion: A staging system based on this conceptual model of cerebrovascular pathology could enable the neuropathologic quantification of the cerebrovascular burden in dementia. Further studies are needed to determine whether this system can be used in large-scale studies to understand clinical-cerebrovascular pathologic correlations.
Figures



Comment in
-
Cerebrovascular pathology in cognitive impairment: new (in)sights.Neurology. 2012 Apr 3;78(14):1032-3. doi: 10.1212/WNL.0b013e31824e8fb4. Epub 2012 Feb 29. Neurology. 2012. PMID: 22377812 No abstract available.
-
Staging and natural history of cerebrovascular pathology in dementia.Neurology. 2012 Jul 3;79(1):107; author reply 107. doi: 10.1212/01.wnl.0000416262.36658.49. Neurology. 2012. PMID: 22753449 No abstract available.
References
-
- O'Brien JT, Erkinjuntti T, Reisberg B, et al. Vascular cognitive impairment. Lancet Neurol 2003; 2: 89–98 - PubMed
-
- Neuropathology Group of the Medical Research Council Cognitive Function and Aging Study (MRC CFAS) Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001; 357: 169–175 - PubMed
-
- Vermeer SE, Prins LD, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM. Silent brains infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003; 348: 1215–1222 - PubMed
-
- van der Flier WM, van Straaten EC, Barkhof F, et al. Small vessel disease and general cognitive function in nondisabled elderly: the LADIS study. Stroke 2005; 36: 2116–2120 - PubMed
-
- Jellinger KA, Attems J. Prevalence and pathogenic role of cerebrovascular lesions in Alzheimer disease. J Neurol Sci 2005; 229–230: 37–41 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical